Founded in 2000, Cathay Biotech Inc. is a globally leading biotechnology company. Focusing on integrated polyamide industrial chain, Cathay Biotech utilizes bio-manufacturing technology to realize research, development, production, and sales of innovative materials. Cathay Biotech has a range of large-scale industrialized biotechnologies, including bio-converted long-chain dicarboxylic acids, bio-based 1,5-pentanediamine, and bio-based polyamide. Distinguished by "renewable, recyclable, and cost-effective" properties, Cathay Biotech's products find applications across diverse industries, such as automotive, electronic & electrical (E&E), smartphone, apparel, textile, etc. Currently, Cathay Biotech is developing technologies for fiber-reinforced bio-based polyamide composites, aiming to provide lightweight, eco-friendly solutions for sectors including alternative energy, green building, logistics, oil and gas pipes etc. In the future, Cathay Biotech will continue to advance the development of green monomers and high-performance green biomaterials to meet the growing market demand for low-carbon products. Cathay Biotech is committed to adopting clean energy and advancing its technology to build an integrated green industrial chain. By prioritizing the balance between environmental stewardship, societal impact, and corporate governance, Cathay aims to establish itself as a leader in sustainable biomaterial development.